IAIM
BNTX icon

International Assets Investment Management’s BioNTech BNTX Stock Holding History

International Assets Investment Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,934
Closed -$151 – 956
2024
Q3 		$151 Buy
+17,934
New +$1.65M ﹤0.01% 1582

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

International Assets Investment Management's BNTX Position: Q4 2024 in Review

International Assets Investment Management sold out of BioNTech (BNTX) in Q4 2024, closing a stake of 17,934 shares — an estimated $151 sold.

International Assets Investment Management first reported a position in BNTX in Q3 2024 and held it in 1 quarter. The position peaked at $151 in Q3 2024. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • International Assets Investment Management reported no remaining BioNTech position as of Q4 2024 after selling out during the quarter.
  • International Assets Investment Management sold 17,934 BioNTech shares in Q4 2024, an estimated $151.
  • International Assets Investment Management first reported a position in BioNTech in Q3 2024 and held it in 1 quarter.
  • International Assets Investment Management's BioNTech position peaked at $151 in Q3 2024.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.